COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 3

Uso de suero anti SARS-COV-2 de convalecientes para el tratamiento de pacientes con COVID-19

INTRODUCCIÓN: El plasma de convalecientes también llamado inmunoterapia, es usualmente elegido cuando no existen medicamentos específicos o vacunas disponibles para casos de infecciones emergentes. Un meta-análisis realizado por Mair-Jenkins et al., mostró que la mortalidad se redujo después de la ...

Utilização de plasma convalescente para tratamento de COVID-19

ANÁLISE: A Covid-19 é uma doença infecciosa causada pelo coronavírus 2 da Síndrome Respiratória Aguda Grave (SRAG) (abreviado para SARS-CoV-2, do inglês Severe Acute Respiratory Syndrome Coronavirus 2), que apresenta amplo espectro clínico, com manifestações respiratórias, digestivas e sistêm...